Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Ground-breaking multi-disciplinary research is to be launched today by the University of Oxford into the impact of poverty and social inequalities in early childhood, thanks to major funding from the Leverhulme Trust.

Young child holding soft toy

Fifteen doctoral scholarships, funded by a £1.35 million Leverhulme Trust award, will span the social and biological sciences with the aim of reducing the impact of these disadvantages on children’s life chances.

One in five children in low-income countries lives in extreme poverty, while declining living standards over the last decade has resulted in a quarter of children in the UK now being affected by poverty.

Led by Professor Jane Barlow, Chair in Evidence-Based Intervention and Policy Evaluation, the Leverhulme Trust Biopsychosocial Doctoral Scholarships scheme will be the first doctoral programme to bring together expertise from diverse disciplines with the explicit goal of reducing the impact of social inequality in early childhood through the application of biological science. The programme will encompass Oxford’s Departments of Social Policy and Intervention, Sociology, Psychiatry, and Experimental Psychology.

Read the full story on the University of Oxford website.

Similar stories

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.